Biotech & Life Sciences investors in Israel

    8 funds

    Gatsbie lists 8 Biotech & Life Sciences investors headquartered in Israel (as of 2026-10-24).

    Most are based in Tel Aviv (2), Darien (1) and Herzliya (1); the most common stages are Seed (6), Series A (6) and Series B (5); the most common kinds of capital are Venture equity (7), Growth equity (4) and Buyout (2).

    8 funds

    1. AUREC CAPITAL

      Ramat Gan, Israel

      Stages: Pre-Seed, Seed, Series A

      Sectors: Logistics & Supply Chain, Consumer Apps, E-commerce & Marketplace, Artificial Intelligence

    2. FIMI Opportunity Funds

      Tel Aviv, Israel

      Stages: Mature

      Sectors: Mobility & Transportation, Hardware & IoT, Logistics & Supply Chain, Space & Aerospace

    3. peregrine

      Or Yehuda, Israel

      Stages: Seed, Series A, Series B, Series C+

      Sectors: Healthcare & MedTech, Biotech & Life Sciences, Enterprise Software

    4. Pitango

      Darien, Israel

      Stages: Pre-Seed, Seed, Series A, Series B

      Sectors: Artificial Intelligence, E-commerce & Marketplace, Financial Services, Healthcare & MedTech

    5. STAR Ventures

      Herzliya, Israel

      Stages: Series B, Series C+

      Sectors: Enterprise Software, Data & Analytics, Media & Entertainment, Biotech & Life Sciences

    6. ALIVE Israel HealthTech Fund

      Tel Aviv, Israel

      Stages: Seed, Series A, Series B, Series C+

      Sectors: Healthcare & MedTech, Artificial Intelligence, Biotech & Life Sciences, Hardware & IoT

    7. Amoon Fund

      Paris, Israel

      Stages: Pre-Seed, Seed, Series A, Series C+

      Sectors: Hardware & IoT, Healthcare & MedTech, Biotech & Life Sciences, Financial Services

    8. Terra Venture Partners

      Jerusalem, Israel

      Stages: Pre-Seed, Seed, Series A, Series B

      Sectors: Healthcare & MedTech, AgTech & FoodTech, CleanTech & Climate, Data & Analytics

    Biotech & Life Sciences investors elsewhere

    Other sectors in Israel

    Counted by where each fund is headquartered, from public sources, as of 2026-10-24. Funds that invest across sectors are included, as in Investor Discovery.